secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001824293-26-000030
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio expands ATM equity offering capacity from $10M to $60M via H.C. Wainwright amendment
--------------------------------------------------------------------------------

- Amendment to At The Market Offering Agreement increases aggregate offering price to $60 million.
- Prior cap was $10 million; amended agreement effective January 28, 2026.
- Waivers obtained from December 2025 Securities Purchase Agreement investor to permit ATM issuances.
- Prospectus supplement filed Jan 29, 2026 to register up to $60M of common stock.
- Sales agent remains H.C. Wainwright & Co., LLC; shares sold at market prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429326000030/0001824293-26-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429326000030/val-20260129.htm
  HTML page:      https://secwatch.observer/filing/0001824293-26-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer